The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect

References

• Buscemi G, Perego P, Carenini N, Nakanishi M, Chessa L, Chen J, Khanna K, Delia D. 2004. Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 23: 7691–7700.
   PubMedGoogle Scholar
• Chen H, Pong RC, Wang Z, Hsieh JT. 2002. Differential regulation of the human gene DAB2IP in normal and malignant prostatic epithelia: Cloning and characterization. Genomics 79:573–581.
   PubMedGoogle Scholar
• Dote H, Toyooka S, Tsukuda K, Yano M, Ota T, Murakami M, Naito M, Toyota M, Gazdar AF, Shimizu N. 2005. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. Br J Cancer 92:1117–1125.
   PubMedGoogle Scholar
• Dote H, Toyooka S, Tsukuda K, Yano M, Ouchida M, Doihara H, Suzuki M, Chen H, Hsieh JT, Gazdar AF, et al. 2004. Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer. Clin Cancer Res 10:2082–2089.
   PubMed Web of Science ®Google Scholar
• Durant ST, Nickoloff JA. 2005. Good timing in the cell cycle for precise DNA repair by BRCA1. Cell Cycle 4:1216–1222.
   PubMed Web of Science ®Google Scholar
• Gapud EJ, Sleckman BP. 2011. Unique and redundant functions of ATM and DNA-PKcs during V(D)J recombination. Cell Cycle 10:1928–1935.
   PubMed Web of Science ®Google Scholar
• Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC. 2004. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64:9152–9159.
   PubMed Web of Science ®Google Scholar
• Hinata N, Shirakawa T, Zhang Z, Matsumoto A, Fujisawa M, Okada H, Kamidono S, Gotoh A. 2003. Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells. Urol Res 31:387–396.
   PubMedGoogle Scholar
• Kobayashi J, Iwabuchi K, Miyagawa K, Sonoda E, Suzuki K, Takata M, Tauchi H. 2008. Current topics in DNA double-strand break repair. J Radiat Res 49:93–103.
   PubMed Web of Science ®Google Scholar
• Kong Z, Raghavan P, Xie D, Boike T, Burma S, Chen D, Chakraborty A, Hsieh JT, Saha D. 2010a. Epothilone B confers radiation dose enhancement in DAB2IP gene knock-down radioresistant prostate cancer cells. Int J Radiat Oncol Biol Phys 78:1210–1218.
   PubMed Web of Science ®Google Scholar
• Kong Z, Xie D, Boike T, Raghavan P, Burma S, Chen DJ, Habib AA, Chakraborty A, Hsieh JT, Saha D. 2010b. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation. Cancer Res 70:2829–2839.
   PubMed Web of Science ®Google Scholar
• Koning CC, Blank LE, Koedooder C, van Os RM, van de Kar M, Jansen E, Battermann JJ, Beijert M, Gernaat C, van Herpen KA, et al. 2012. Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors. Ann Oncol 23:2948–2953.
   PubMedGoogle Scholar
• Löbrich M, Shibata A, Beucher A, Fisher A, Ensminger M, Goodarzi AA, Barton O, Jeggo PA. 2010. gammaH2AX foci analysis for monitoring DNA double-strand break repair: Strengths, limitations and optimization. Cell Cycle 9:662–669.
   PubMed Web of Science ®Google Scholar
• Moyer VA. 2011. Screening for bladder cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 155:246–251.
   PubMedGoogle Scholar
• Pawlik TM, Keyomarsi K. 2004. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59:928–942.
   PubMed Web of Science ®Google Scholar
• Qiu GH, Xie H, Wheelhouse N, Harrison D, Chen GG, Salto-Tellez M, Lai P, Ross JA, Hooi SC. 2007. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma. J Hepatol 46:655–663.
   PubMedGoogle Scholar
• Sandler HM, Mirhadi AJ. 2012. Current role of radiation therapy for bladder cancer. Semin Oncol 39:583–587.
   PubMedGoogle Scholar
• Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. 2000. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 151:1381–1390.
   PubMed Web of Science ®Google Scholar
• Shen YJ, Kong ZL, Wan FN, Wang HK, Bian XJ, Gan HL, Wang CF, Ye DW. 2014. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer. Cancer Sci 105:704–712.
   PubMed Web of Science ®Google Scholar
• Shrivastav M, De Haro LP, Nickoloff JA. 2008. Regulation of DNA double-strand break repair pathway choice. Cell Res 18:134–147.
   PubMed Web of Science ®Google Scholar
• Shrivastav M, Miller CA, De Haro LP, Durant ST, Chen BP, Chen DJ, Nickoloff JA. 2009. DNA-PKcs and ATM co-regulate DNA double-strand break repair. DNA Repair (Amst) 8:920–929.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, Jemal A. 2013. Cancer statistics, 2013. CA Cancer J Clin 63:11–30.
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, et al. 2001. Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients. J Clin Oncol 19:666–675.
   PubMed Web of Science ®Google Scholar
• Veuger SJ, Curtin NJ, Richardson CJ, Smith GC, Durkacz BW. 2003. Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1. Cancer Res 63:6008–6015.
   PubMed Web of Science ®Google Scholar
• Wang Z, Tseng CP, Pong RC, Chen H, McConnell JD, Navone N, Hsieh JT. 2002. The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase- activating protein associated with N-terminal domain of DOC-2/DAB2. J Biol Chem 277:12622–12631.
   PubMedGoogle Scholar
• White D, Rafalska-Metcalf IU, Ivanov AV, Corsinotti A, Peng H, Lee SC, Trono D, Janicki SM, Rauscher FJ 3rd. 2012. The ATM substrate KAP1 controls DNA repair in heterochromatin: Regulation by HP1 proteins and serine 473/824 phosphorylation. Mol Cancer Res 10:401–414.
   Google Scholar
• Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H, et al. 2010. Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. Proc Natl Acad Sci USA 107:2485–2490.
   PubMed Web of Science ®Google Scholar
• Xie D, Gore C, Zhou J, Pong RC, Zhang H, Yu L, Vessella RL, Min W, Hsieh JT. 2009. DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc Natl Acad Sci USA 106:19878–19883.
   PubMed Web of Science ®Google Scholar
• Yafi FA, Aprikian AG, Chin JL, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, et al. 2011. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: A Canadian multicentre experience. BJU Int 108:539–545.
   PubMed Web of Science ®Google Scholar
• Yano M, Toyooka S, Tsukuda K, Dote H, Ouchida M, Hanabata T, Aoe M, Date H, Gazdar AF, Shimizu N. 2005. Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers. Int J Cancer 113:59–66.
   PubMed Web of Science ®Google Scholar
• Yazdi PT, Wang Y, Zhao S, Patel N, Lee EY, Qin J. 2002. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 16:571–582.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang R, Luo Y, D’Alessio A, Pober JS, Min W. 2004. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. J Biol Chem 279:44955–44965.
   PubMed Web of Science ®Google Scholar